First Page | Document Content | |
---|---|---|
![]() Date: 2014-10-02 03:37:36Amides Organochlorides Pharmacology Benzazepines Diuretics Otsuka Pharmaceutical Aripiprazole Tolvaptan Nabiximols Chemistry Pharmaceutical sciences Organic chemistry | Add to Reading List |
![]() | Medical Hypotheses, 234–246 http://intl.elsevierhealth.com/journals/mehy A tale of two cannabinoids: The therapeutic rationale for combiningDocID: 1pj4f - View Document |
![]() | Cannabinoids and Multiple Sclerosis – M.J.Atha © IDMU Ltd 2006 Cannabinoids and Multiple Sclerosis A Literature reviewDocID: 17DzR - View Document |
![]() | Microsoft PowerPoint - Wayne Hall.ppt [Compatibility Mode]DocID: 10SLB - View Document |
![]() | O’Shaughnessy’s • Summer 2003 —17— Bayer Buys Rights to Market GWP’s Cannabis Extract By Fred Gardner GW Pharmaceuticals, the British company that has conducted successful clinical trials of cannabis-basedDocID: 10QP8 - View Document |
![]() | PH ARMACEUTICAL SEGMENT Otsuka-people creating new products for better health worldwide Pharmaceutical Segment OverviewDocID: T3F4 - View Document |